Detection, Monitoring and Cell Kinetics of Circulating CAR-T Cells in B-Cell Malignancies

被引：0
|
作者：
Sierro, Belen [1 ]
Beatriz Garcia-Calderon, Clara [1 ]
Sanoja-Flores, Luzalba [1 ]
Ruiz-Maldonado, Victoria [1 ]
Delgado Serrano, Javier [1 ]
Molinos-Quintana, Agueda [1 ]
Luis Reguera, Juan [1 ]
Guijarro-Albaladejo, Beatriz [1 ]
Reinoso-Segura, Marta [1 ]
Garcia-Guerrero, Estefania [1 ]
Perez-Simon, Jose A. [1 ]
Caballero, Teresa [1 ]
机构：
[1] Univ Seville, Inst Biomed Sevilla IBiS, Hosp Univ Virgen del Rocio, UGC Hematol,CSIC,CIBERONC, Seville, Spain
来源：
BLOOD | 2022年 / 140卷
关键词：
D O I：
10.1182/blood-2022-163106
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：7550 / 7551
页数：2
相关论文
共 50 条
  • [1] Monitoring of kinetics and exhaustion markers of circulating CAR-T cells as early predictive factors in patients with B-cell malignancies
    Garcia-Calderon, Clara Beatriz
    Sierro-Martinez, Belen
    Garcia-Guerrero, Estefania
    Sanoja-Flores, Luzalba
    Munoz-Garcia, Raquel
    Ruiz-Maldonado, Victoria
    Jimenez-Leon, Maria Reyes
    Delgado-Serrano, Javier
    Molinos-Quintana, Agueda
    Guijarro-Albaladejo, Beatriz
    Carrasco-Brocal, Inmaculada
    Lucena, Jose-Manuel
    Garcia-Lozano, Jose-Raul
    Blazquez-Goni, Cristina
    Reguera-Ortega, Juan Luis
    Gonzalez-Escribano, Maria-Francisca
    Reinoso-Segura, Marta
    Briones, Javier
    Perez-Simon, Jose Antonio
    Caballero-Velazquez, Teresa
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [2] Multi Targeted CAR-T Cell Therapies for B-Cell Malignancies
    Shah, Nirav N.
    Maatman, Theresa
    Hari, Parameswaran
    Johnson, Bryon
    FRONTIERS IN ONCOLOGY, 2019, 9
  • [3] CAR-T Therapy Beyond B-Cell Hematological Malignancies
    Canichella, Martina
    de Fabritiis, Paolo
    CELLS, 2025, 14 (01)
  • [4] Selecting the Optimal CAR-T for the Treatment of B-Cell Malignancies
    Al-Juhaishi, Taha
    Ahmed, Sairah
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2021, 16 (01) : 32 - 39
  • [5] Selecting the Optimal CAR-T for the Treatment of B-Cell Malignancies
    Taha Al-Juhaishi
    Sairah Ahmed
    Current Hematologic Malignancy Reports, 2021, 16 : 32 - 39
  • [6] Switch-mediated activation and retargeting of CAR-T cells for B-cell malignancies
    Rodgers, David T.
    Mazagova, Magdalena
    Hampton, Eric N.
    Cao, Yu
    Ramadoss, Nitya S.
    Hardy, Ian R.
    Schulman, Andrew
    Du, Juanjuan
    Wang, Feng
    Singer, Oded
    Ma, Jennifer
    Nunez, Vanessa
    Shen, Jiayin
    Woods, Ashley K.
    Wright, Timothy M.
    Schultz, Peter G.
    Kim, Chan Hyuk
    Young, Travis S.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2016, 113 (04) : E459 - E468
  • [7] Bispecific CAR T-cells for B-cell Malignancies
    Furqan, Fateeha
    Shah, Nirav N.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2022, 22 (08) : 1005 - 1015
  • [8] Relapse after CAR-T cell therapy in B-cell malignancies: challenges and future approaches
    Gu, Tianning
    Zhu, Meng
    Huang, He
    Hu, Yongxian
    JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B, 2022, 23 (10): : 793 - 811
  • [9] Central Nervous System Relapse after CAR-T Cell Therapy in B-Cell Malignancies
    Gu, Tianning
    Huang, Wenfa
    Wang, Lei
    Li, Yuqi
    Wang, Lixin
    Hu, Yongxian
    Huang, He
    BLOOD, 2022, 140 : 13220 - 13221
  • [10] CAR-T and other adoptive cell therapies for B cell malignancies
    Lu, Peihua
    Hill, Holly A.
    Navsaria, Lucy J.
    Wang, Michael L.
    JOURNAL OF THE NATIONAL CANCER CENTER, 2021, 1 (03): : 88 - 96
12345